ANTIPHOSPHOLIPID SYNDROME (APS)
Clinical trials for ANTIPHOSPHOLIPID SYNDROME (APS) explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME (APS) trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME (APS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy trial aims to tame severe autoimmune diseases in children
Disease control Not yet recruitingThis early-stage study tests a new cell therapy called YTS109 in 12 children aged 5 to 17 with severe autoimmune diseases like lupus and scleroderma that haven't responded to standard treatments. The therapy is given as a single IV infusion, and the main goals are to check its sa…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase: PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 26, 2026 09:25 UTC
-
New drug trial aims to tame rare clotting disorder
Disease control Not yet recruitingThis study tests the safety of an experimental drug called anifrolumab in 20 adults with antiphospholipid syndrome (APS), a condition that raises the risk of blood clots and pregnancy complications. Participants receive weekly injections for a year alongside their usual treatment…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase: PHASE2 • Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated May 22, 2026 14:03 UTC